Induction of Efflux-Mediated Macrolide Resistance in Streptococcus pneumoniae
暂无分享,去创建一个
[1] W. Shafer,et al. Human Antimicrobial Peptide LL-37 Induces MefE/Mel-Mediated Macrolide Resistance in Streptococcus pneumoniae , 2010, Antimicrobial Agents and Chemotherapy.
[2] D. Farrell,et al. Increase in Pneumococcus Macrolide Resistance, United States , 2009, Emerging infectious diseases.
[3] A. Mankin,et al. Induction of erm(C) Expression by Noninducing Antibiotics , 2008, Antimicrobial Agents and Chemotherapy.
[4] P. Wayne. PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING, NINTH INFORMATIONAL SUPPLEMENT , 2008 .
[5] R. Koncan,et al. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae. , 2007, The Journal of antimicrobial chemotherapy.
[6] R. Hakenbeck,et al. A new integrative reporter plasmid for Streptococcus pneumoniae. , 2007, FEMS microbiology letters.
[7] A. Bogdanov,et al. Peptide derivatives of tylosin-related macrolides , 2007, Russian Journal of Bioorganic Chemistry.
[8] A. Kwon,et al. ermK leader peptide: Amino acid sequence critical for induction by erythromycin , 2006, Archives of pharmacal research.
[9] J. Claverys,et al. Antibiotic Stress Induces Genetic Transformability in the Human Pathogen Streptococcus pneumoniae , 2006, Science.
[10] M. Mulvey,et al. Expression of the mef(E) Gene Encoding the Macrolide Efflux Pump Protein Increases in Streptococcus pneumoniae with Increasing Resistance to Macrolides , 2005, Antimicrobial Agents and Chemotherapy.
[11] D. Stephens,et al. Macrolide Efflux in Streptococcus pneumoniae Is Mediated by a Dual Efflux Pump (mel and mef) and Is Erythromycin Inducible , 2005, Antimicrobial Agents and Chemotherapy.
[12] Steven D. Brown,et al. Emergence and Spread of Streptococcus pneumoniae with erm(B) and mef(A) Resistance , 2005, Emerging infectious diseases.
[13] K. Klugman,et al. Hidden Epidemic of Macrolide-resistant Pneumococci , 2005, Emerging infectious diseases.
[14] A. Schuchat,et al. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment , 2005, The Lancet.
[15] J. Poehlsgaard,et al. The structural basis of macrolide-ribosome binding assessed using mutagenesis of 23S rRNA positions 2058 and 2059. , 2004, Journal of molecular biology.
[16] S. Doktor,et al. Characterization and Prevalence of MefA, MefE, and the Associated msr(D) Gene in Streptococcus pneumoniae Clinical Isolates , 2004, Journal of Clinical Microbiology.
[17] D. Bejuk. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci]. , 2004, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.
[18] G. Syrogiannopoulos,et al. Antimicrobial Susceptibility and Macrolide Resistance Inducibility of Streptococcus pneumoniae Carrying erm(A), erm(B), or mef(A) , 2003, Antimicrobial Agents and Chemotherapy.
[19] R. Berisio,et al. Structural Insight into the Antibiotic Action of Telithromycin against Resistant Mutants , 2003, Journal of bacteriology.
[20] Frank Schluenzen,et al. Structural insight into the role of the ribosomal tunnel in cellular regulation , 2003, Nature Structural Biology.
[21] S. Connell,et al. Erythromycin, roxithromycin, and clarithromycin: use of slow-binding kinetics to compare their in vitro interaction with a bacterial ribosomal complex active in peptide bond formation. , 2003, Molecular pharmacology.
[22] Poul Nissen,et al. The structures of four macrolide antibiotics bound to the large ribosomal subunit. , 2002, Molecular cell.
[23] K. Klugman,et al. Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections , 2002, European Respiratory Journal.
[24] P. Braga. Rokitamycin: Bacterial Resistance to a 16-Membered Ring Macrolide Differs from that to 14- and 15-Membered Ring Macrolides , 2002, Journal of chemotherapy.
[25] F. Schluenzen,et al. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria , 2001, Nature.
[26] D. Stephens,et al. Structure and dissemination of a chromosomal insertion element encoding macrolide efflux in Streptococcus pneumoniae. , 2001, The Journal of infectious diseases.
[27] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[28] B. Vester,et al. Inhibition of the ribosomal peptidyl transferase reaction by the mycarose moiety of the antibiotics carbomycin, spiramycin and tylosin. , 2000, Journal of molecular biology.
[29] M. P. Montanari,et al. In vitro activity of ketolides telithromycin and HMR 3004 against italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility. , 2000, The Journal of antimicrobial chemotherapy.
[30] J. Claverys,et al. Cross‐regulation of competence pheromone production and export in the early control of transformation in Streptococcus pneumoniae , 2000, Molecular microbiology.
[31] A. Schuchat,et al. The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment. , 2000, The Journal of infectious diseases.
[32] J. Karlowsky,et al. Ribosomal resistance: Emerging problems and potential solutions , 1999, Current infectious disease reports.
[33] Ryochi Fujii,et al. Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics. , 1999, The Journal of antimicrobial chemotherapy.
[34] J. Claverys,et al. Development of competence in Streptococcus pneumoniae: pheromone autoinduction and control of quorum sensing by the oligopeptide permease , 1998, Molecular microbiology.
[35] W. Yuan,et al. mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae , 1997, Antimicrobial agents and chemotherapy.
[36] A. Girard,et al. Ketolides lack inducibility properties of MLS(B) resistance phenotype. , 1997, The Journal of antimicrobial chemotherapy.
[37] B. Weisblum,et al. Induction of ermSV by 16-membered-ring macrolide antibiotics , 1997, Antimicrobial agents and chemotherapy.
[38] A. Kamath,et al. Molecular cloning and functional analysis of a novel macrolide‐resistance determinant, mefA, from Streptococcus pyogenes , 1996, Molecular microbiology.
[39] T. Grebe,et al. Detection of erythromycin-resistant determinants by PCR , 1996, Antimicrobial agents and chemotherapy.
[40] J. Claverys,et al. Competence pheromone, oligopeptide permease, and induction of competence in Streptococcus pneumoniae , 1996, Molecular microbiology.
[41] J. Sutcliffe,et al. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system , 1996, Antimicrobial agents and chemotherapy.
[42] D. Morrison,et al. An unmodified heptadecapeptide pheromone induces competence for genetic transformation in Streptococcus pneumoniae. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[43] B. Weisblum,et al. Insights into erythromycin action from studies of its activity as inducer of resistance , 1995, Antimicrobial agents and chemotherapy.
[44] B. Weisblum,et al. Transcriptional attenuation control of ermK, a macrolide-lincosamide-streptogramin B resistance determinant from Bacillus licheniformis , 1991, Journal of bacteriology.
[45] D. Morrison,et al. Genetic transformation in Streptococcus pneumoniae: nucleotide sequence analysis shows comA, a gene required for competence induction, to be a member of the bacterial ATP-dependent transport protein family , 1991, Journal of bacteriology.
[46] J. Wootton,et al. Inducible erythromycin resistance in staphlyococci is encoded by a member of the ATP‐binding transport super‐gene family , 1990, Molecular microbiology.
[47] M. Mayford,et al. The ermC leader peptide: amino acid alterations leading to differential efficiency of induction by macrolide-lincosamide-streptogramin B antibiotics , 1990, Journal of bacteriology.
[48] B. Weisblum,et al. Erythromycin-induced ribosome stall in the ermA leader: a barricade to 5'-to-3' nucleolytic cleavage of the ermA transcript , 1989, Journal of bacteriology.
[49] M. Mayford,et al. ermC leader peptide. Amino acid sequence critical for induction by translational attenuation. , 1989, Journal of molecular biology.
[50] B. Lampson,et al. Novel mechanism for plasmid-mediated erythromycin resistance by pNE24 from Staphylococcus epidermidis , 1986, Antimicrobial Agents and Chemotherapy.
[51] Jeffrey H. Miller. Experiments in molecular genetics , 1972 .